Intellia Therapeutics (NTLA) Capital Expenditures (2015 - 2026)
Intellia Therapeutics (NTLA) reported Capital Expenditures of $79000.0 for Q1 2026, down 3.66% year-over-year from $82000.0 in Q1 2025, and up 146.88% on a QoQ basis from $32000.0 in Q4 2025.
Intellia Therapeutics (NTLA) has 12 years of Capital Expenditures data on file, last reported at $79000.0 in Q1 2026.
- Quarterly Capital Expenditures fell 3.66% year-over-year to $79000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29000.0 (up 101.57% YoY) and the FY2025 annual result came in at $32000.0, down 94.45% from the prior year.
- Capital Expenditures climbed to $79000.0 in Q1 2026 per NTLA's latest filing, from $32000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $4.3 million in Q2 2023 and bottomed at -$6.6 million in Q3 2023.
- The 5-year median for Capital Expenditures is $885000.0 (2022), against an average of $985687.5.
- The widest annual swing landed in 2022, when Capital Expenditures soared 312.99%; it then tumbled 15529.63% in 2024.
- Tracing NTLA's Capital Expenditures over 5 years: stood at $3.9 million in 2022, then tumbled by 100.69% to -$27000.0 in 2023, then plunged by 15529.63% to -$4.2 million in 2024, then jumped by 100.76% to $32000.0 in 2025, then surged by 146.88% to $79000.0 in 2026.
- Per Business Quant, the three latest NTLA Capital Expenditures figures stand at $79000.0 (Q1 2026), $32000.0 (Q4 2025), and -$82000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Intellia Therapeutics | 1.63 Bn | 1.63 Bn | - | 79,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79,000.00 |
| Mar 31, 2026 | 79,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Jun 30, 2025 | -82,000.00 |
| Jun 30, 2025 | -82,000.00 |
| Mar 31, 2025 | 82,000.00 |
| Mar 31, 2025 | 82,000.00 |
| Dec 31, 2024 | -4.22 Mn |
| Dec 31, 2024 | -4.22 Mn |
| Sep 30, 2024 | 4.17 Mn |
| Sep 30, 2024 | 4.17 Mn |
| Jun 30, 2024 | -1.88 Mn |
| Jun 30, 2024 | -1.88 Mn |
| Mar 31, 2024 | 2.51 Mn |
| Mar 31, 2024 | 2.51 Mn |
| Dec 31, 2023 | -27,000.00 |
| Dec 31, 2023 | -27,000.00 |
| Sep 30, 2023 | -6.58 Mn |
| Sep 30, 2023 | -6.58 Mn |
| Jun 30, 2023 | 4.30 Mn |
| Jun 30, 2023 | 4.30 Mn |
| Mar 31, 2023 | 3.83 Mn |
| Mar 31, 2023 | 3.83 Mn |
| Dec 31, 2022 | 3.91 Mn |
| Dec 31, 2022 | 3.91 Mn |
| Sep 30, 2022 | 4.24 Mn |
| Sep 30, 2022 | 4.24 Mn |
| Jun 30, 2022 | 1.69 Mn |
| Jun 30, 2022 | 1.69 Mn |
| Mar 31, 2022 | 3.72 Mn |
| Mar 31, 2022 | 3.72 Mn |
| Dec 31, 2021 | 2.87 Mn |
| Dec 31, 2021 | 2.87 Mn |
| Sep 30, 2021 | 4.54 Mn |
| Sep 30, 2021 | 4.54 Mn |
| Jun 30, 2021 | 4.45 Mn |
| Jun 30, 2021 | 4.45 Mn |
| Mar 31, 2021 | 901,000.00 |
| Mar 31, 2021 | 901,000.00 |
| Dec 31, 2020 | -1.07 Mn |
| Dec 31, 2020 | -1.07 Mn |
| Sep 30, 2020 | 2.15 Mn |
| Sep 30, 2020 | 2.15 Mn |
| Jun 30, 2020 | -413,000.00 |
| Jun 30, 2020 | -413,000.00 |
| Mar 31, 2020 | 845,000.00 |
| Mar 31, 2020 | 845,000.00 |
| Dec 31, 2019 | 2.57 Mn |
| Dec 31, 2019 | 2.57 Mn |
| Sep 30, 2019 | 3.36 Mn |
| Sep 30, 2019 | 3.36 Mn |
| Jun 30, 2019 | 421,000.00 |
| Jun 30, 2019 | 421,000.00 |
| Mar 31, 2019 | 446,000.00 |
| Mar 31, 2019 | 446,000.00 |
| Dec 31, 2018 | -3.70 Mn |
| Dec 31, 2018 | -3.70 Mn |
| Sep 30, 2018 | 3.35 Mn |
| Sep 30, 2018 | 3.35 Mn |
| Jun 30, 2018 | -433,000.00 |
| Jun 30, 2018 | -433,000.00 |
| Mar 31, 2018 | 1.85 Mn |
| Mar 31, 2018 | 1.85 Mn |
| Dec 31, 2017 | 9.49 Mn |
| Dec 31, 2017 | 9.49 Mn |
| Sep 30, 2017 | -4.83 Mn |
| Sep 30, 2017 | -4.83 Mn |
| Jun 30, 2017 | 5.06 Mn |
| Jun 30, 2017 | 5.06 Mn |
| Mar 31, 2017 | 378,000.00 |
| Mar 31, 2017 | 378,000.00 |
| Dec 31, 2016 | 330,000.00 |
| Dec 31, 2016 | 330,000.00 |
| Sep 30, 2016 | 605,000.00 |
| Sep 30, 2016 | 605,000.00 |
| Jun 30, 2016 | 1.24 Mn |
| Jun 30, 2016 | 1.24 Mn |
| Mar 31, 2016 | 918,000.00 |
| Mar 31, 2016 | 918,000.00 |
| Dec 31, 2015 | 2.41 Mn |
| Dec 31, 2015 | 2.41 Mn |
| Sep 30, 2015 | -959,000.00 |
| Sep 30, 2015 | -959,000.00 |
| Jun 30, 2015 | 587,000.00 |
| Jun 30, 2015 | 587,000.00 |
| Mar 31, 2015 | 516,000.00 |
| Mar 31, 2015 | 516,000.00 |